Clinical Trial Update: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and efficacy of Hetrombopag Olamine in patients with immune thrombocytopenia (ITP), sponsored by Jiangsu HengRui Medicine Co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Hetrombopag Olamine (Hetrombopag)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Chronic Idiopathic Thrombocytopenic Purpura | Phase 1 | Status: UNKNOWN